LHDX
Market cap | $18.36 Million |
---|---|
Enterprise Value | $26.68 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1.86 |
Beta | 3.76 |
Outstanding Shares | 40,216,244 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.24 |
---|---|
PEG | -0.07 |
Price to Sales | 0.09 |
Price to Book Ratio | 0.45 |
Enterprise Value to Revenue | 0.13 |
Enterprise Value to EBIT | -0.19 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 1.8 |
Debt to Equity | 0.79 |
No data
No data
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-...